|
Use of nonhuman data
|
—a
|
Appeared to rely mostly on human data, although some animal data are mentioned
|
|
Description of limitations
|
—a
|
—a
|
|
Description of literature search strategy
|
General types of sources are described, but specifics of the search strategy are not
|
General types of sources are described but specifics of the search strategy are not
|
|
Use of current literature
|
Original Commission E monographs were completed in 1994; assessment of literature used is not possible because it is not cited
|
Includes references from the year 2000
|
|
Starting assumptions/appearance of impartiality
|
Translation sponsored by ABC (including corporate members), but it is assumed to replicate the original Commission E findings
|
Sponsored by ABC (including corporate members)
|
|
Use of peer review
|
—a
|
Text indicates “streamlined peer review process” was employed, but also indicates additional information provided in the expanded text was not subject to the level of review conducted by Commission E
|
|
Focus on a particular standardized product and discussion of preparation impact on safety
|
Preparation impact on safety is not specifically discussed; safety conclusions are assumed to be based on standardizations described because conclusions were made for the German marketplace
|
Specific preparations were not addressed except for two botanicals (Echinacea and hawthorne), where confusion existed from Commission E; safety conclusions are based on products standardized for the German marketplace
|
|
Description of consumption levels considered
|
Recommendations for therapeutic doses are included, so it is assumed that these are the intake levels on which safety judgments are made
|
Recommendations for therapeutic doses as in the Commission E translation, so it is assumed that these are the intake levels on which safety judgments are made
|